For research and educational purposes only. Not medical advice.
Thymosin Alpha-1 Reference
Educational, not medical advice reference for Thymosin Alpha-1: Immune, Longevity; regulatory status, evidence posture, source review, and sched…
Reference summary
Compared with most peptides in this library, thymosin alpha-1 has deeper human clinical literature. Even so, indication-specific trial results are mixed and should not be generalized to broad 'immune support' use.
Regulatory and posture
- Categories
- Immune, Longevity
- Aliases
- Thymosin-alpha 1, Ta1, Zadaxin (outside US)
- Evidence posture
- human - Human data are indication-specific, not broad wellness evidence.
- Regulatory status
- No FDA-approved thymosin alpha-1 drug label in the United States. Published randomized human trials exist in hepatitis B and immune-related conditions, but US use remains investigational and FDA lists thymosin-alpha 1 among bulk substances with safety-risk concerns.
- Content review status
- research reference
Selected public sources
- FDA bulk drug substances with significant safety risks
- PubMed: thymosin alpha-1 HBV trial
- PubMed: thymosin alpha-1 ACLF trial
Related tools
- Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
- BAC water calculator - Solve BAC water volume for a target concentration.
- Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
- Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.